🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don't forget to check out our webinar today discussing the key updates from ESC! You can find us streaming at Asian Pacific Society of Cardiology Facebook and Youtube channels

Excited to present obicetrapib data from the ROSE trial at #AHA21 a new pathway for CETP inhibitors Michael Davidson MD Douglas Kling John Kastelein and friends @VicHeartInst Monash University

Join us as we summarise some of the key updates from AHA on Saturday the 27th of November 2021. Streaming LIVE from Asian Pacific Society of Cardiology Facebook and Youtube. 5.00-6.30pm AEDT 2.00-3.30pm SGT 3.00-4.30pm JST

Thanks for invitation Yeo KK Steve Nicholls Asian Pacific Society of Cardiology The Asia Pacific Cardiometabolic Consortium #ESCardioAsia. 50% of CVD is in APAC region...need to understand barriers to guideline-based care & rigorously evaluate strategies to overcome them. Hopefully GOAL-Asia will move the needle Julie Butters

Calling all doctors! We'd like to elucidate the differences in statin usage across the Asia Pacific region. If you have a spare 5-10 minutes please complete our survey! You can access it at our website. 📝 apcmc.net/what-we-do/pro…

So good to see this online!! ⁦Steve Nicholls⁩ Giuseppe Di Giovanni⁩ Effect of Evolocumab on Changes in Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction | JACC: Cardiovascular Imaging jacc.org/doi/pdf/10.101…

Thank you to everyone who has been able to join us in person for our e2p Heart Symposium. It’s been a long time coming but it is great to be able to meet up again in person and decipher what the last couple of years of trials mean to our clinical practice #heartsymposium22

So good to be back face to face in Milan Steve Nicholls European Atherosclerosis Society #EAScongress2022

See this consensus statement on current pharmacological prevention and management of HF. Statement constructed by a faculty group assembled by Evidence to Practice .

The INVICTUS study showing that in RHD-AF, compared to rivaroxaban,VKAs have a lower mortality and reduced ischemic stroke without increasing the risk of major bleeding. VKAs should remain the standard of care in RHD-AF

PACIFIC-AMI demonstrating that Asundexian 50mg daily on top of DAPT resulted in near complete (>90%) inhibition of factor Xla inhibition following acute MI #ESCCongress

Speed dating of ESC Clinical Trial results by the E2P faculty Steve Nicholls Adam Nelson Claire Arnott John Amerena, John Atherton and Chris Hammett.

✅ Consensus recommendations of The Asia Pacific Cardiometabolic Consortium on secondary prevention strategies in #MI, covering #pharmacotherapy, lifestyle modification and cardiac rehab 👉 bit.ly/3RarZMw

Fabulous to be in the room at acc2 :) to see this positive trial presented and great news for statin intolerant patients Steve Nicholls Monash Victorian Heart Institute

This Thursday, 16th March at 8.00pm AEDT via Asian Pacific Society of Cardiology Steve Nicholls will summarise the results from the CLEAR Outcomes trial. Join Steve and our panel as we discuss this important trial and the new option it presents for patients with statin intolerance.

We're excited to announce enrollment in our Phase 3 BROOKLYN trial is complete, several months ahead of schedule. Our ability to quickly enroll HeFH patients who haven't met their LDL-c goals shows the urgent need for new, potent lipid-lowering therapies. bit.ly/41AqBHs

Great to see this published The Asia Pacific Cardiometabolic Consortium. Really highlights the need for improved inclusion of Asia Pacific Investigators and participants in trials moving forward. We all need to do better.

Hone your skills, learn from some of the best - join our free masterclass this Saturday. Monash Victorian Heart Institute #cardiology #masterclass

Your plans for tomorrow night are sorted! ✅ Join us online, or in person at the Victorian Heart Hospital, for our free Women's Heart Masterclass delivered by our expert faculty from 6.00pm. Registration essential → bit.ly/womensheartmas…

Exciting day with more obicetrapib data for at ⁦⁦European Atherosclerosis Society⁩ with publications in ⁦NEJM⁩ and ⁦The Lancet⁩ ⁦John Kastelein⁩ ⁦Prof Kausik Ray FMedSci⁩ ⁦Michael Davidson MD⁩ ⁦Adam Nelson⁩ ⁦Julie Butters⁩ ⁦Monash Victorian Heart Institute⁩ ⁦NewAmsterdam Pharma Corporation⁩